Network meta-analysis of integrated traditional Chinese and Western medicine in the treatment of Sjogren’s syndrome

Network meta-analysis of integrated traditional Chinese and Western medicine in the treatment of Sjogren’s syndrome

ObjectiveTo evaluate efficacy and safety of traditional Chinese medicine (TCM) combined with Western medicine in treatment of Sjogren’s syndrome (SS).MethodsCNKI, WanFang, VIP, CBM, Sinomed, PubMed, Embase, and Web of Science were searched to collect randomized controlled trials (RCTs) of TCM combin...

Full description

Saved in:

Bibliographic Details
Main Authors:	Xieli Ma, Zixia Liu, Tian Chang, Chuanhui Yao, Yuchen Yang, Biyue Shang, Jiameng Liu, Congmin Xia, Xun Gong, Quan Jiang
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2024-11-01
Series:	Frontiers in Pharmacology
Subjects:	Sjogren’s syndrome Chinese patent medicine tripterygium wilfordii polyglycosides tablets total glucosides of paeony capsule network meta-analysis randomized controlled
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2024.1455969/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Research on nanoemulsion for increasing effects and reducing toxicity of Tripterygium wilfordii polyglycosides
by: HE Xin, et al.
Published: (2008-05-01)

A network Meta-analysis of tripterygium wilfordii polyglycosides tablet,ambrette capsule and RAS blocker in the treatment of IgA nephropathy
by: FANG Xin-ying, et al.
Published: (2020-01-01)

Genome-wide characterization and expression analysis of WRKY family genes in the biosynthesis of triptolide in Tripterygium wilfordii
by: Limei Tang, et al.
Published: (2025-04-01)

The emerging role of mitochondria in the pharmacological and toxicological effects of Tripterygium wilfordii Hook F: functions, targets and new therapeutic applications
by: Zhonghao Liu, et al.
Published: (2025-07-01)

Therapeutic potential and pharmacological insights of total glucosides of paeony in dermatologic diseases: a comprehensive review
by: Huige Wang, et al.
Published: (2025-01-01)

Multi-target mechanism of Tripteryguim wilfordii Hook for treatment of ankylosing spondylitis based on network pharmacology and molecular docking
by: Jing Zhang, et al.
Published: (2021-01-01)

Meta-analysis of efficacy and safety of multi-glycoside of Tripterygium wilfordii in the treatment of idiopathic membranous nephropathy
by: YIN Song-jiang, et al.
Published: (2016-01-01)

Progress on Tripterygium wilfordii Hook f. as a treatment option for neurodegenerative diseases
by: Zhong-mou Zhang, et al.
Published: (2024-12-01)

The effects of Tripterygium wilfordii Hook F on renal outcomes in type 2 diabetic kidney disease patients with severe proteinuria: a single-center cohort study
by: Yaqi Cheng, et al.
Published: (2024-12-01)

Effectiveness of rehmannia glutinosa combined with tripterygium glycosides in treatment of idiopathic membranous nephropathy and prognostic analysis
by: GUO Bo-hui, et al.
Published: (2019-01-01)

Add-on effects of total glucosides of paeony on conventional therapies for psoriasis: a systematic review and meta-analysis of randomized controlled trials
by: Ziqing Li, et al.
Published: (2025-02-01)

A Triple Therapeutic Regiment Consisted of Colchicine, Thalidomide and Total Glucosides of Paeony Is Effective and Well‐Tolerated for Treating Mucocutaneous Involvement in Patients With Behcet's Disease
by: Jian‐Fei Cai, et al.
Published: (2024-12-01)

Therapeutic effects and mechanisms of Tripterygium wilfordii extracts in rheumatoid arthritis: a systematic review and meta-analysis of preclinical studies
by: Kai Chen, et al.
Published: (2025-07-01)

Structure Characterization of Four New Sesquiterpene Pyridine Alkaloids from <i>Tripterygium wilfordii</i> Hook. f. and Anti-Inflammatory Activity Evaluations
by: Yong-Jian Wang, et al.
Published: (2024-11-01)

Mechanisms of Total Glucosides of Paeony in Alleviating Methotrexate-Induced Liver Injury
by: Chen GY, et al.
Published: (2025-04-01)

Total Glucosides of Paeony (TGP) Inhibits Macrophages Infiltration and NLRP3-Mediated Inflammatory Response in Acute Gouty Arthritis Mice
by: Liu J, et al.
Published: (2025-07-01)

Effects of total glucosides from paeony on the expression of auto-inflammatory factors and serum NGAL,TLR4 and MYD88 in maintenance hemodialysis patients
by: HU Wen-xing, et al.
Published: (2020-01-01)

The evolution of international classification criteria for Sjogren’s syndrome
by: J. I. Khvan, et al.
Published: (2024-01-01)

ARTICULAR DAMAGE IN SJOGREN’S DISEASE
by: N S Shornikova, et al.
Published: (2002-02-01)

Pulmonary Involvement Caused by Primary Sjogren’s Syndrome: The Pilot phase of Iran Primary Sjogren’s Syndrome Registry
by: Asghar Hajiabbasi, et al.
Published: (2025-07-01)

The redesign of amoxicillin capsules as a tablet dosage form using direct compression
by: Salem Elgahmi, et al.
Published: (2019-01-01)

Investigating the common genes involved in development of Sjogren's syndrome and Cardiomyopathy
by: Anwer Aldhaheri, et al.
Published: (2025-06-01)

Diagnostic value of tongue manifestations for primary Sjögren’s syndrome: construction and validation of disease screening model
by: Jia-qi Chen, et al.
Published: (2025-05-01)

Serum CA125, CA199, estradiol, FSH, IL-6, TNF-a in endometriosis after administration of Tripterygium wilfordii glycosides
by: Xu Fangdan, et al.
Published: (2025-01-01)

Meibomian gland dysfunction in Sjögren's disease
by: Esther N. Anuwa-Amarh, et al.
Published: (2025-08-01)

Development of Celecoxib Granules for Manufacturing of Prolonged Release Celecoxib Capsules and Tablets
by: A. Alkhodri, et al.
Published: (2022-02-01)

The relation between corneal optical quality and clinical ocular surface manifestations in Chinese female with Sjogren’s syndrome dry eye
by: Jingyu Zhang, et al.
Published: (2025-07-01)

Genetic insight into dissecting the immunophenotypes and inflammatory profiles in the pathogenesis of Sjogren syndrome
by: Jingyi Xu, et al.
Published: (2025-01-01)

A Retrospective Cohort Study of Chinese Herbal Medicine Reducing the Risk of Readmission of Rheumatoid Arthritis Complicated with Sjogren's Syndrome
by: CHEN Xiaolu, LIU Jian
Published: (2025-04-01)

Sjögren sendromu ve granülomatöz polianjiitis birlikteliği gösteren bir olgu
by: Sema Yılmaz, et al.
Published: (2019-12-01)

Prevalence of solid tumors and lymphoma in the Brazilian Sjögren’s Disease Registry (BRAS): an important concern for clinical practice
by: Virginia Fernandes Moça Trevisani, et al.
Published: (2025-08-01)

Tripterygium glycosides improve abnormal lipid deposition in nephrotic syndrome rat models
by: Bidan Zheng, et al.
Published: (2023-12-01)

Sjogren's syndrome: a neurological perspective
by: Orlando Grazianni Povoas Barsottini, et al.
Published: (2023-12-01)

Efficacy of Shenshuaining combined with medicinal charcoal tablets in the treatment of hemodialysis patients with hyperphosphatemia
by: HANG Wan-chao
Published: (2016-01-01)

PROFILE OF NEUROLOGICAL MANIFESTATIONS IN PRIMARY SJOGREN’S SYNDROME
by: M S Panchovska, et al.
Published: (2002-06-01)

Membranous nephropathy in a patient with Sjögren’s disease
by: Kubra Kaynar, et al.
Published: (2025-05-01)

Ultrasonography of the salivary glands in Sjögren's disease: own data analysis
by: Yu. I. Khvan, et al.
Published: (2024-10-01)

One patient with Sjogren&rsquo;s syndrome presenting schizophrenia-like symptoms
by: Lin C
Published: (2016-03-01)

Obesity: Friend or Foe in Sjögren’s Syndrome Patients?
by: Kincső Mezei, et al.
Published: (2024-12-01)

Sjögren: unique surname, two men, four syndromes and one disease
by: José Vitor Alécio Rodrigues, et al.
Published: (2024-04-01)